US 12188060
Messenger RNA encoding Cas9 for use in genome-editing systems
granted A61KA61K31/7088A61K48/00
Quick answer
US patent 12188060 (Messenger RNA encoding Cas9 for use in genome-editing systems) held by CRISPR THERAPEUTICS AG expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/7088, A61K48/00, A61K48/005, A61K9/5123